AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03718442 — intervention group
Intervention type: DEVICE
Intervention: PhotonBlade vs Bovie for lumpectomy shaved surgical margins
Description: For each enrolled patient, six shaved margins will be obtained (superior, inferior, medial, lateral, anterior, and posterior). For each patient, electrocautery will be used to obtain 3 of the shaved margins, and PhotonBlade to obtain the other 3 shaved margins. Once the lumpectomy site shaved margins have been obtained, the shaved surgical margins will be evaluated by a pathologist whom is blinded in regards to the dissection device that was used for each margin. The pathologist will be evaluating each shaved margin and reporting the outcomes (qualitative severity and depth of thermal artifact)
Study NCT02678676 — intervention group
Intervention type: OTHER
Intervention: No Intervention
Description: Participants who previously received Pioglitazone in the PROactive study (NCT00174993).
Study NCT02678676 — intervention group
Intervention type: OTHER
Intervention: No Intervention
Description: Participants who previously received pioglitazone-matching placebo in the PROactive study (NCT00174993).
Study NCT02029534 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Atorvastatin 20 mg
Study NCT02029534 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg
Study NCT03886558 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: A multicomponent intervention program was developed consisting of two 60-minute sessions per week, held on non-consecutive days, for a period of 8 months.
Description: The sessions consisted of a warm-up phase (10') in which individuals performed joint mobility exercises and walked at a rate of 3 km/h. Afterwards, muscular strength work was carried out on the upper and lower limbs, including calisthenic exercises, and the use of dumbbells or medicine balls (1-3kg). Generally, the exercises were organized in two sets of 10-15 repetitions, resting for two minutes between sets. Communal ball games and relay games were then practiced (over a distance of 30 meters). Finally, 10 minutes were devoted to relaxation and stretching exercises. multicomponent intervention program was designed and monitored by a specialist in gerontogymnastics.
Study NCT01955057 — intervention group
Intervention type: BEHAVIORAL
Intervention: Research interviews
Study NCT01955057 — intervention group
Intervention type: BEHAVIORAL
Intervention: Tests (Fagerström, Q-MAT, H.A.D.S, SCL 90-R)
Study NCT01955057 — intervention group
Intervention type: BEHAVIORAL
Intervention: Projective methods (Thematic apperception Test, Rorschach)
Study NCT01955057 — intervention group
Intervention type: BEHAVIORAL
Intervention: Carbon monoxide test
Study NCT02194868 — intervention group
Intervention type: BIOLOGICAL
Intervention: Recipients
Description: 1. Adult recipient:~   * collected 20 ml pre-transplant~  * collected 30 ml for adults on day 20 post-transplant at engraftment for cell phenotype,~  * collected 30 ml on days 30, 60, 90, 180, 360 days post-HSCT for cell phenotyping at all time points, functional INKT at day 60 or 90 depending on the number of cells collected and anti-viral ELISPOT studies on days 180 and 360~2. Children recipients~   * collected residual blood pre-transplant~  * collected residual blood on day 20 post-transplant at engraftment for cell phenotype,~  * collected residual blood on days 20, 30, 90, 180 and 360 post-HSCT
Study NCT02194868 — intervention group
Intervention type: BIOLOGICAL
Intervention: Donors
Description: 1. Adult donors :~   * collected 20 ml of blood, (if possible before granulocyte colony-stimulating factor (GCSF) administration)~  * collected 1 ml of the stem cell graft for adult recipient or 2 ml of bone marrow for children recipients These samples will be collected at the same time of those needed for transplant.~2. Children donors samples~   * collected residual blood~  * 2ml of bone marrow (bottom of tube)
Study NCT00543764 — intervention group
Intervention type: OTHER
Intervention: pathway
Description: Comparison of pre and post pathway
Study NCT02692677 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNJ-42756493
Description: Participants will receive a single oral solution at a dose of 12 milligram (mg) of unlabeled JNJ--42756493 admixed with 14C- labeled JNJ--42756493.
Study NCT05300295 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mentoring Program
Description: The Autism Mentorship Program is a psychosocial intervention that pairs adults and adolescents with autism spectrum disorder (ASD) in one-to-one mentoring relationships. AMP involves weekly meetings in an afterschool setting and targets the socio-emotional health and social connectedness of adolescents and adults with ASD.
Study NCT02330796 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bucillamine
Description: Bucillamine Tablets
Study NCT01786915 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Study NCT04109573 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: high resolution anal manometry
Description: functional studies before and after anal laser ablation
Study NCT01791166 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Blood test for detecting the circulatory anti-HLA antibodies by ELISA and LUMINEX tests
Study NCT05103462 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telehealth Physical Therapy
Description: Weekly sessions of physical therapy provided using two-way, interactive, video technology consisting of education, advice and exercise instruction.
Study NCT03142282 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: maintenance chemotherapy
Description: National Comprehensive Cancer Network (NCCN) or European Society for Medical Oncology (ESMO) suggested maintenance chemotherapy regimens: xeloda, bevacizumab
Study NCT03142282 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Consolidative Radiotherapy
Description: Stereotacticbodyradiationtherapy (SBRT) or intensity modulated radiation therapy (IMRT) for metastatic sites (less than 5)
Study NCT01136317 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Omeprazole
Study NCT02330796 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Colchicine
Study NCT02630784 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Non-Invasive Ventilation with Homecare ventilator
Study NCT02630784 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Non-Invasive Ventilation with ICU ventilator
Study NCT02239809 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Stimulation of the trigeminal nerve (active stimulation)
Description: Participants will be randomized to active vs. sham stimulation during a period of 24 weeks with a one-way cross over at 12 weeks.~After 12 weeks, the participants receiving active electrical stimulation will continue under active stimulation until completion of the study.~Participants randomized to sham stimulation will be shifted to active stimulation and will be followed-up until completion of the study.~The study will be unblinded after 6 months of randomized stimulation. The second part of the study will be an open label prospective trial for evaluate long-term follow-up. The duration of the open label trial will be more 24 weeks.
Study NCT02239809 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Placebo stimulation of the trigeminal nerve (placebo)
Description: Participants will be randomized to active vs. sham stimulation during a period of 24 weeks with a one-way cross over at 12 weeks. Patients of the placebo group will be implanted with a lead in the V1 branch of the trigeminal nerve, but will not receive stimulation.~After 12 weeks, the participants receiving active electrical stimulation will continue under active stimulation until completion of the study.~Participants randomized to placebo stimulation will be shifted to active stimulation and will be followed-up until completion of the study.~The study will be unblinded after 6 months of randomized stimulation. The second part of the study will be an open label prospective trial for evaluate long-term follow-up. The duration of the open label trial will be more 24 weeks.
Study NCT03258827 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Exercise with a towel
Description: Exercise program composes with warm-up, strengthening exercise, cold-down, 60 minutes/time, 3 times/week. A towel is an important tool for exercise. Total duration of the program is 3 months.
Study NCT01786915 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT04453137 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Adalimumab originator
Description: Subcutaneous injection every other week
Study NCT04453137 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Adalimumab originator
Description: Subcutaneous injection every other week
Study NCT04453137 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Adalimumab biosimilar
Description: Subcutaneous injection every other week
Study NCT00959634 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ABT-126
Description: Dose administered twice daily on Study Days 1-10
Study NCT01136317 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rabeprazole
Study NCT01136317 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Lactose
Study NCT04058665 — intervention group
Intervention type: DEVICE
Intervention: Floseal
Description: Hemostatic agent
Study NCT03292770 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Flushing Catheter
Description: A catheter will be used to performed a flushing of the cervical canal with culture media.
Study NCT03364699 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: dietary supplementation
Description: The volunteers ingested 3 g daily of Soybean lecithin or fish oil rich in docosa-hexanoic acid (DHA) containing 1.5 g DHA and 0.3 g EPA (DHA:EPA = 5:1) or fish oil rich in eicosapentaenoic acid (EPA) containing 1.6 g EPA and 0.3 g DHA (EPA:DHA = 5.4:1) during 60 days.
Study NCT03364699 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: dietary supplementation
Description: The volunteers ingested 3 g daily of Soybean lecithin or fish oil rich in docosa-hexanoic acid (DHA) containing 1.5 g DHA and 0.3 g EPA (DHA:EPA = 5:1) or fish oil rich in eicosapentaenoic acid (EPA) containing 1.6 g EPA and 0.3 g DHA (EPA:DHA = 5.4:1) during 60 days.
Study NCT03364699 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: All volunteers performed two half-marathons. In the first half-marathon, all participants were not supplemented. In the second half-marathon, all participants were supplemented. Blood samples were collected before and after both half-marathon race.
Study NCT04899531 — intervention group
Intervention type: OTHER
Intervention: Longitudinal observation
Description: No specific intervention, longitudinal (pre-post measurements) only
Study NCT03698058 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Toddler milk
Description: Commercially available toddler milk
Study NCT03698058 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Toddler milk
Description: Commercially available toddler milk
Study NCT05298527 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Back Massage
Description: The woman lies face down and a pillow is placed under her forehead. Massage begins with effleurage. Petrissage is started from the sacrum and the hands are lifted up to the nape and repeated 4 times. After the petrissage movement is completed, effusion is applied to the area once. Friction is applied. After rubbing, tapotement is applied to the entire back.
Study NCT02876211 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paricalcitol
Description: Paricalcitol 2 capsules/three times per week
Study NCT02876211 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Epoetin beta
Description: epoetin 1-3 times per week
Study NCT02876211 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Epoetin beta
Description: epoetin 1-3 times per week
Study NCT02876211 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo 2 capsules/three times per week
Study NCT00712608 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Infant formula
Description: Marketed cow's milk base infant formula 20 kcal/oz
Study NCT00712608 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Infant formula
Description: cow's milk based infant formula with prebiotics, different level of fatty acids and fat and a different calcium source
Study NCT00712608 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cow's milk infant formula
Description: Cow's milk based formula with prebiotics, different level of fatty acids and fat and a different calcium source
Study NCT04620356 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DryNites Pyjama Pants
Description: DryNites Pyjama Pants are disposable, absorbent youth pants designed to help children manage bed wetting by absorbing involuntary urine loss and protecting the child's garments and bedding. DryNites Pyjama Pants are underwear-like alternatives that can be discreetly worn beneath pyjamas or nightwear during the bedwetting phase.
Study NCT01939236 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: traditional Chinese medicine
Description: 1 bag of drug 2 times per day for 28 days according to syndrome differentiation. For example, the syndrome of one patient is qi deficiency and blood stasis, he will take drugs of qi deficiency and blood stasis each bag 2 times per day for 28days.
Study NCT01939236 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (gummeline)
Description: Placebo of each syndrome differentiation has the same weight and smell as traditional Chinese medicine of corresponding syndrome differentiation.~1 bag of drug 2 times per day for 28 days according to syndrome differentiation.~For example, the syndrome of one patient is qi deficiency and blood stasis, he will take drugs of qi deficiency and blood stasis each bag 2 times per day for 28 days.
Study NCT02358720 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Arm A
Description: 1x24Gy high dose IMRT on spinal bone metastasis
Study NCT02358720 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Arm B
Description: fractionated conformal RT 10 x 3 Gy on spinal bone metastasis
Study NCT02138227 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Assisted CEaD Condition
Description: In the assisted condition, participants use the CEaD training materials supplemented with simulators to practice the communication skills. OPO requesters will be assisted by having the CEaD DVD supplemented through working the scenarios with live simulated patients who will be trained to act out the scenarios with the OPO requesters and provide feedback.
Study NCT02138227 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Autonomous CEaD Condition
Description: In the autonomous condition, participants view the CEaD training materials on a DVD along with a self-training guide.
Study NCT02551900 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Warm water exercise
Description: Warm water based cycling exercise training program will be based on cycling in warm water (temperature 34◦C ). Warm water exercise will be conducted at moderate intensity (60-70% maximum heart rate). The three groups were exercise 15 minutes on the first month, second month will be increased to 20 minutes and the last month will be increased to 30 minutes. The training program will be performed 3 times per week for 12 weeks.
Study NCT02551900 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Warm water exercise
Description: Warm water based cycling exercise training program will be based on cycling in warm water (temperature 34◦C ). Warm water exercise will be conducted at moderate intensity (60-70% maximum heart rate). The three groups were exercise 15 minutes on the first month, second month will be increased to 20 minutes and the last month will be increased to 30 minutes. The training program will be performed 3 times per week for 12 weeks.
Study NCT02551900 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cold water exercise
Description: Cold water based cycling exercise training will be based on cycling in cold water (temperature 20◦C ). Cold water exercise will be conducted at moderate intensity (60-70% maximum heart rate). The three groups were exercise 15 minutes on the first month, second month will be increased to 20 minutes and the last month will be increased to 30 minutes. The training program will be performed 3 times per week for 12 weeks.
Study NCT02551900 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Land based cycling exercise
Description: Land based cycling exercise training will be based on ride a bicycle ergometer (Monark 894e, Sweden). Land based cycling exercise training will be conducted at moderate intensity (60-70% maximum heart rate). The three groups were exercise 15 minutes on the first month, second month will be increased to 20 minutes and the last month will be increased to 30 minutes. The training program will be performed 3 times per week for 12 weeks.
Study NCT01016912 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BMS-790052
Description: Tablets, Oral, 10 mg, daily, 24-48 weeks
Study NCT01016912 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BMS-790052
Description: Tablets, Oral, 60 mg, daily, 24-48 weeks
Study NCT01016912 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Tablets, Oral, 0 mg, daily, 48 weeks
Study NCT01016912 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Peginterferon alfa-2b
Description: Syringe, Subcutaneous, 180µg, weekly, 24-48 weeks
Study NCT01016912 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Peginterferon alfa-2b
Description: Syringe, Subcutaneous, 180µg, weekly, 24-48 weeks
Study NCT01016912 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ribavirin
Description: Capsules, Oral, 600 to 1000 mg based on weight, daily, 24-48 weeks
Study NCT01016912 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Ribavirin
Description: Capsules, Oral, 600 to 1000 mg based on weight, daily, 24-48 weeks
Study NCT00204711 — intervention group
Intervention type: OTHER
Intervention: SNAP II EEG System
Description: A portable EEG monitor (SNAP II EEG System, Everest -St. Louis) is unique in that it monitors both low frequency EEG signals (1-40 Hz), which are typically used, and high frequency EEG signals (80-420 Hz), which are not usually used, and calculates a derived EEG parameter (the SNAP Index). The SNAP Index ranges from 100 (completely awake) to 0 (no brain activity) and has been shown in a few studies to correlate with increasing sedation and loss of consciousness in human volunteers and patients receiving general anesthesia during surgery.
Study NCT02173470 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CT scan
Description: The intervention group receives both standard care (chest x-ray) and an ultra low dose CT thorax without contrast.
Study NCT03094468 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: P-3058 (terbinafine hydrochloride 10%)
Description: Patients will apply the P-3058 nail solution once weekly in a double blind fashion. The overall treatment phase is of 48 weeks.
Study NCT03094468 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Vehicle of P-3058
Description: Patients will apply the Vehicle of P-3058 once weekly in a double blind fashion. The overall treatment phase is of 48 weeks.
Study NCT03735056 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MS Nurse Support
Description: MS Nurse Support intervention is multi-faceted, involving various components (i.e. information provision and emotional support), and a range of strategies and techniques (e.g. psychoeducation, acceptance and commitment), delivered by MS Nurse Specialists, to provide standardised support and advice to patients at diagnosis, to establish and sustain coping strategies. MS Nurse Support intervention is person-centred and tailored to the needs and lifestyle of each participant.
Study NCT03735056 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Peer Support
Description: Peer Support will be delivered by Peer Support Workers using information provision and supportive listening to provide support and advice to patients at diagnosis, and to provide patients the opportunity to talk freely, extensively and confidentially about their experiences, thoughts and feelings about MS diagnosis and its effects on their lives in a non-judgmental and safe environment. Peer Support intervention is person-centred and tailored to the needs and lifestyle of each participant.
Study NCT00132665 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: A: Radiotherapy alone
Description: Procedure/Surgery: A: Radiotherapy alone
Study NCT00132665 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: B: CBDCA and Radiotherapy
Description: Drug: B: CBDCA and Radiotherapy
Study NCT01274104 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Vitamin D3
Description: 15,000 IU of Vitamin D3 every day for 14 days
Study NCT01274104 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT03007680 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Core muscle activation
Study NCT02919709 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: blood taking
Study NCT01778673 — intervention group
Intervention type: PROCEDURE
Intervention: Cast immobilization
Study NCT04271423 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ridge Preservation
Description: Ridge Preservation using demineralized bone matrix and mineralized particulate allograft and covered with calcium sulfate barrier.